# A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis

> **NCT00579956** · NA · UNKNOWN · sponsor: **University of Oxford** · enrollment: 750 (estimated)

## Conditions studied

- Melioidosis

## Interventions

- **DRUG:** Meropenem
- **DRUG:** Ceftazidime

## Key facts

- **NCT ID:** NCT00579956
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2008-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579956, "A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00579956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*